Literature DB >> 27443998

Neuroimaging in Central Nervous System Lymphoma.

Seyed Ali Nabavizadeh1, Arastoo Vossough2, Mehrdad Hajmomenian2, Reza Assadsangabi2, Suyash Mohan3.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare aggressive high-grade type of extranodal lymphoma. PCNSL can have a variable imaging appearance and can mimic other brain disorders such as encephalitis, demyelination, and stroke. In addition to PCNSL, the CNS can be secondarily involved by systemic lymphoma. Computed tomography and conventional MRI are the initial imaging modalities to evaluate these lesions. Recently, however, advanced MRI techniques are more often used in an effort to narrow the differential diagnosis and potentially inform diagnostic and therapeutic decisions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT; Central nervous system; Lymphoma; MRI

Mesh:

Year:  2016        PMID: 27443998     DOI: 10.1016/j.hoc.2016.03.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  13 in total

Review 1.  [Differential diagnoses of ischemic stroke using imaging].

Authors:  U Yilmaz
Journal:  Radiologe       Date:  2019-07       Impact factor: 0.635

Review 2.  Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.

Authors:  Andrés José María Ferreri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.

Authors:  Rupsa Bhattacharjee; Mamta Gupta; Tanu Singh; Shalini Sharma; Gaurav Khanna; Suhail P Parvaze; Rana Patir; Sandeep Vaishya; Sunita Ahlawat; Anup Singh; Rakesh Kumar Gupta
Journal:  Neuroradiology       Date:  2022-04-18       Impact factor: 2.995

Review 4.  Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.

Authors:  Junfeng Zhang; Heng Liu; Haipeng Tong; Sumei Wang; Yizeng Yang; Gang Liu; Weiguo Zhang
Journal:  Contrast Media Mol Imaging       Date:  2017-03-20       Impact factor: 3.161

5.  Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.

Authors:  Dong Won Baek; Hee Jeong Cho; Jae Heung Bae; Sang Kyun Sohn; Joon Ho Moon
Journal:  Blood Res       Date:  2020-06-30

6.  Primary Central Nervous System Lymphoma with Exclusive Leptomeningeal Involvement: The Diagnostic Challenge of a Rare Presentation of an Uncommon Disease.

Authors:  Miguel Santos; Tatiana Pires; Ana Rodrigues; Adriana Bandeira; Ana Albuquerque; Flávia Santos; Miriam Magalhães; Maria Jesus Banza
Journal:  Eur J Case Rep Intern Med       Date:  2022-01-27

7.  Primary peripheral T-cell central nervous system lymphoma.

Authors:  Cylaina E Bird; Jeffrey I Traylor; Jenna Thomas; James P Caruso; Benjamin Kafka; Flavia Rosado; Kyle M Blackburn; Kimmo J Hatanpaa; Kalil G Abdullah
Journal:  Surg Neurol Int       Date:  2021-09-13

8.  Primary Central Nervous System Lymphoma Mimicking Longitudinally Extensive Transverse Myelitis.

Authors:  Prashant Anegondi Natteru; Shashank Shekhar; Lakshmi Ramachandran Nair; Hartmut Uschmann
Journal:  Neurohospitalist       Date:  2020-10-16

Review 9.  Primary central nervous system lymphoma.

Authors:  Sarah Löw; Catherine H Han; Tracy T Batchelor
Journal:  Ther Adv Neurol Disord       Date:  2018-10-05       Impact factor: 6.570

10.  Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study.

Authors:  Tianwang Guan; Zicong Qiu; Miao Su; Jinming Yang; Yongshi Tang; Yanting Jiang; Dunchen Yao; Yanxian Lai; Yanfang Li; Cheng Liu
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.